Company profile: Okairos
1.1 - Company Overview
Company description
- Provider of biopharmaceutical discovery and development of genetic T-cell vaccines, including for hepatitis C virus, and health and allied services. Based in Basel, Switzerland, with operations in Rome and Naples, Italy.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Okairos
Miacom Diagnostics
HQ: Germany
Website
- Description: Provider of microbiological tools for pathogen identification, manufacturing laboratory equipment, medical devices, and electrosurgery machines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Miacom Diagnostics company profile →
AIM ImmunoTech
HQ: United States
Website
- Description: Provider of immuno-pharmaceutical therapeutics centered on Ampligen, an immuno-modulator evaluated for cancer, immunodeficiency disorders and viral diseases, and approved in Argentina for severe chronic fatigue syndrome. Operates an Early Access Program in the Netherlands for pancreatic cancer, runs Phase 2 and combinational therapy trials in solid tumors, and studies ME/CFS and post-COVID conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AIM ImmunoTech company profile →
Specific Diagnostics
HQ: United States
Website
- Description: Provider of patented medical device technology leveraging a low-cost small molecule sensor to enable diagnostic products that simplify workflow and speed time-to-answer at a low cost.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Specific Diagnostics company profile →
DNAe
HQ: United Kingdom
Website
- Description: Provider of rapid near-patient molecular diagnostics, offering the LiDia-SEQ platform for direct-from-specimen DNA sequencing on a microchip; BSI/AMR test detecting bloodstream infections and antimicrobial resistance from whole blood; a sample preparation system extracting pathogens via immunomagnetic beads; semiconductor sequencing technology; and an oncology program for tumor DNA monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DNAe company profile →
InDevR
HQ: United States
Website
- Description: Provider of microarray technologies and novel solutions for the life science industry, including ampliPHOX Colorimetric Detection Technology for identification and differentiation of viruses such as Crimean-Congo hemorrhagic fever virus.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InDevR company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Okairos
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Okairos
2.2 - Growth funds investing in similar companies to Okairos
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Okairos
4.2 - Public trading comparable groups for Okairos
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →